Las Vegas, Nevada – June 19, 2017 (GLOBE NEWSWIRE) – Envoy Group Corp. (ENVV) (the “Company” or “Envoy”), is pleased to announce its acquisition of the Blockchain technology development company, BitReturn.
BitReturn, located in British Columbia (BC), Canada, is an advanced technology company with a focus on developing powerful Blockchain applications to streamline and transform existing industries. The BitReturn team has more than 20 years of experience in pioneering business applications development, most recently with its build of a robust and secure platform for Bignition which was sold to AutoTrader.ca.
Envoy, in conjunction with BitReturn, has created a focused rollout program that includes the design, innovative uses, and the marketing of BitReturn’s robust and hyper-secure Blockchain applications. Phase One of this program is targeting the lucrative Digital Currency Mining operation that we have de-risked by housing the process in our secure Tier 3 Data Center Facility in British Columbia, Canada. Hundreds of Nvidia and Advanced Micro Devices (AMD) Graphic Processor units (GPUs) will power the backbone of the operations.
This initial phase of our rollout strategy recognizes the explosion in the use and acceptance of various Digital Currencies like Bitcoin and Ethereum that are now collectively valued at over 100 Billion US Dollars, and the critical importance of Blockchain technology in enabling their use.
“This initial entry into currency mining operations marks a strategic milestone for Envoy. The technical expertise of our team complements our corporate finance and strategic planning team,” commented Harp Sangha, CEO of Envoy. “We expect this enterprise will produce positive cash flow early in its rollout that will facilitate our expansion into Phase 2 of the program which will rapidly build revenues and margin.”
About Envoy Group, Corp.
Envoy Group, Corp. (OTC Markets:ENVV) is a company with an extensive market reach and a strategy to identify, evaluate, and develop new business opportunities across North America, Europe and Asia.
Chairman, CEO & CFO
Investor Relations Contact:
Director of Investor Relations
Investor Contact Information
Certain information contained in this news release constitutes “forward-looking statements” as such term is used in applicable United States and Canadian laws. Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as “expects” or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “estimates”, “intends” or “believes”, or that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur”, or “be achieved”. Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made, and are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements. Many of these factors are beyond the Company’s ability to control or predict. Important factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this news release can be found in the Company’s filings with the SEC. Such risks and other factors include, among others, the ability to locate and acquire suitable interests in alternative medicine manufacturing operations on terms acceptable to the Company, the availability of financing on acceptable terms, accidents, labor disputes, acts of God and other risks of the alternative medicine industry including, without limitation, delays in obtaining governmental approvals or permits, title disputes or claims limitations on insurance coverage. The Company believes that the expectations reflected in the forward-looking statements included in this news release are reasonable; however, no assurance can be given that these expectations will prove to be correct, and such forward-looking statements should not be unduly relied upon. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise.